Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
424 hedge funds and large institutions have $9.77B invested in Exact Sciences in 2019 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 130 increasing their positions, 136 reducing their positions, and 42 closing their positions.
131% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 42
38% more capital invested
Capital invested by funds: $7.08B → $9.77B (+$2.69B)
15% more funds holding
Funds holding: 370 → 424 (+54)
4% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 136
1.97% less ownership
Funds ownership: 91.63% → 89.66% (-2%)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
59% less call options, than puts
Call options by funds: $164M | Put options by funds: $404M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$198M |
| 2 |
D.E. Shaw & Co
New York
|
+$59M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$48.9M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$48.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$37.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$133M |
| 2 |
Goldman Sachs
New York
|
-$103M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$63.4M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$55.5M |
| 5 |
Citigroup
New York
|
-$54M |
EXAS Hedge Fund Activity: Q1 2019 in Review
424 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2019, worth a combined $9.77B — up 38% from $7.08B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new EXAS positions and 42 closed out — a net gain of 55 holders — while 130 added to existing stakes and 136 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $198M. The largest seller was T. Rowe Price Associates, cutting an estimated $133M.
- 424 institutional investors held Exact Sciences (EXAS) as of Q1 2019, up from 370 in Q4 2018.
- Funds reported $9.77B of Exact Sciences stock for Q1 2019, up 38% quarter-over-quarter.
- 97 funds opened new Exact Sciences positions in Q1 2019 and 42 closed out, a net change of +55 holders.
- The largest Exact Sciences buyer in Q1 2019 was Winslow Capital Management, an estimated $198M added.
- The largest Exact Sciences seller in Q1 2019 was T. Rowe Price Associates, an estimated $133M sold.
Based on aggregated 13F filings for Q1 2019.